Duramed Research
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, Duramed Research sits in the top decile of US sponsors by registered trial count (#668 of 15,742 sponsors by registered trial count).
Duramed Research: 23 sponsored US clinical trials, none currently recruiting.
Duramed Research sponsors 23 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 23 completed. 14 of these trials are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Contraception, with 1 trials.
Top-decile sponsor footprint
Duramed Research ranks in the top decile of sponsors by registered trial count (#668 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
23 of 23 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
23 total, page 1 of 1
A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females
NCT00924560
A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches
NCT00781456
Emergency Contraception Actual Use Study
NCT00777556
A Safety Extension Study of DR-OXY-301
NCT00782769
A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder
NCT00685113
A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization
NCT00615251
Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal Women
NCT00592839
A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale
NCT00394771
A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001
NCT00382408
Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive
NCT00362479
A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal Atrophy
NCT00361569
A Clinical Trial to Demonstrate the Efficacy and Safety of Cenestin 0.3 mg for the Treatment of Hot Flashes
NCT00272935
A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea
NCT00196391
Comparison of DR-2011 to a Progesterone Vaginal Gel for Luteal Phase Replacement
NCT00117468
A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients
NCT00196339
Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive
NCT00196326
A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens
NCT00117273
Evaluation of DR-2001 for the Management of Endometriosis-Related Pelvic Pain
NCT00117481
A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
NCT00196313
A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
NCT00196365
A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal Atrophy
NCT00196378
Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder
NCT00196404
A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.
NCT00196352
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 9 |
| Phase 3 | 13 |
| Phase 4 | 1 |
Therapeutic Areas
How the Duramed Research archive is shaped
23 indexed studies, none listed as recruiting (0% open); 23 completed (100%).
Phase mix: 14 late (III/IV) vs 9 early (I/II) (later-stage heavy).
Top condition: Contraception (1 trial), 3 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Duramed Research: archived-pipeline peers nationwide
Peers matched on 23 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Duramed Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 23 archived trials
- AMAG Pharmaceuticals · 23 trials · 9% recruiting
- AtriCure · 23 trials · 22% recruiting
- Cara Therapeutics · 23 trials · 0% recruiting
- Craig L Slingluff, Jr · 23 trials · 4% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Duramed Research page
23 registered trials is a research-attention snapshot, not an endorsement of Duramed Research or any single study.
- None of Duramed Research's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Contraception is the condition Duramed Research studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Contraception trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Duramed Research pipeline card: 23 registered trials from official public datasets.Report a data error.